Executive Summary
Repurposing Drugs for New Indications: Benefits and Challenges
Summary: In this webinar executive summary, industry experts share diverse insights about challenges and opportunities with repurposing drugs for new disease treatments.
View Now
Webinars
Then and Now – Delivering a Successful Therapeutic to Patients
Summary: Experts discuss the changing experience from the last quarter of a century in the pathway to patients, and how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing.
View Now
Webinars
Leveraging Advanced Tools to Shorten Biologic Development Timelines
Summary: In this webinar, experts discuss new cell line development methodologies and how the use of novel technologies can enable simplified process intensification for cell culture harvest and downstream processes.
View Now
Article
A Collaborative Effort: How Parallel Approaches and Diverse Partnerships Could Help Combat COVID-19
Summary: In a panel discussion executives from Moderna, Sanofi Pasteur, Takeda and Catalent share behind-the-scenes updates on their respective efforts to develop a COVID-19 vaccine.
View Now
Webinars
Early Phase Biologic Development: Upstream and Downstream Processes Considerations
Summary: In this webinar, experts discuss new cell line development methodologies, including new instrumentation, for clinical and commercial programs.
View Now
Webinars
Repurposing Drugs For New Indications: Benefits and Challenges
Summary: Our panel of experts from Humanigen, Catalent and WYSS Institute discuss the challenges of advancing a repurposed drug to market and how to overcome them to achieve strategic success
View Now
Webinars
Manufacturing Innovation Across New Modalities
Summary: The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities...
View Now
Webinars
Pharma Predictions for 2021
Summary: Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.
View Now
Webinars
Women in Biopharma Awards 2020
Summary: Gwen Green, VP of Commercial Excellence at Catalent, and Endpoints News editors highlight the top 20 women in biopharma who have made it to the upper echelons of the drug development business in this on-demand webinar.
View Now
Webinars
Supply Chain Contingencies to Avoid Upheaval
Summary: Karen Flynn, President of Biologics and Chief Commercial Officer, explains the challenges and opportunities changing how biomedical supply chains must plan and innovate to continue to serve patients and build resilient future options.
View Now